Key Takeaways
- • Ricky Mewani, a healthcare-focused trader at Citadel, is departing the firm to join rival multistrategy hedge fund Balyasny Asset Management following a $50 million loss in his portfolio.
- • Mewani, a former JPMorgan analyst, will take a six-month sabbatical before joining Balyasny, allowing him to begin operations with a clean slate at the new firm.
- • The move represents another portfolio manager exit from Citadel amid what sources describe as a "losing streak" at the hedge fund giant, signaling potential talent attrition during a challenging performance period.
- • Balyasny's recruitment of Mewani reflects competitive pressure among multistrategy hedge funds to attract experienced equity managers, particularly those with specialized sector expertise like healthcare.
Summary
Ricky Mewani is leaving Citadel to join Balyasny Asset Management after sustaining a $50 million loss managing a healthcare stock portfolio at billionaire Ken Griffin's flagship hedge fund. The departure, announced September 22, 2025, marks another senior portfolio manager exit from Citadel during a reported performance downturn at the firm.
Mewani, who previously worked as an analyst at JPMorgan, will take a six-month hiatus before beginning his role at Balyasny, positioning the move as an opportunity to reset operations away from the pressures of his Citadel losses. This transition period provides him with distance from recent underperformance before launching initiatives at the multistrategy rival.
The move underscores competitive dynamics in the hedge fund industry, where top-tier talent commands significant mobility leverage even after material losses. Balyasny's willingness to recruit Mewani—despite his $50 million drawdown—reflects the premium placed on healthcare sector expertise and portfolio management experience within multistrategy operations. For Citadel, the exit compounds concerns about portfolio manager retention during what multiple sources characterize as a losing streak affecting the broader organization.
The timing and circumstances of Mewani's departure illustrate how hedge fund performance volatility can accelerate talent realignment, with established rivals positioned to absorb displaced managers from larger platforms. His sabbatical, rather than immediate transition, suggests negotiated terms that allow both parties a clean separation.
Mewani, who previously worked as an analyst at JPMorgan, will take a six-month hiatus before beginning his role at Balyasny, positioning the move as an opportunity to reset operations away from the pressures of his Citadel losses. This transition period provides him with distance from recent underperformance before launching initiatives at the multistrategy rival.
The move underscores competitive dynamics in the hedge fund industry, where top-tier talent commands significant mobility leverage even after material losses. Balyasny's willingness to recruit Mewani—despite his $50 million drawdown—reflects the premium placed on healthcare sector expertise and portfolio management experience within multistrategy operations. For Citadel, the exit compounds concerns about portfolio manager retention during what multiple sources characterize as a losing streak affecting the broader organization.
The timing and circumstances of Mewani's departure illustrate how hedge fund performance volatility can accelerate talent realignment, with established rivals positioned to absorb displaced managers from larger platforms. His sabbatical, rather than immediate transition, suggests negotiated terms that allow both parties a clean separation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.